Ligand-directed self-assembling chimeras for targeted protein O-GlcNAcylation
December 1, 2025·,,
,,,,,,,,,,,,·
0 min read
Zhihao Guo
Tongyang Xu
Khadija Shahed Khan
Stephan Scheeff
Yao Qin
Sin-Yi Yu
Richard Lo
Yuanpei Li
Yalun Xie
Bowen Ma
Yunpeng Huang
Hillary Yui-Yan Yip
Clive Yik-Sham Chung
Tomonori Tamura
Itaru Hamachi
Billy Wai-Lung Ng
Abstract
Precise control of protein-specific O-GlcNAcylation in cells remains a major challenge. Chemically induced proximity (CIP) offers a promising path forward, but its application to targeted protein O-GlcNAcylation has been limited by the lack of ligands that can bind the O-GlcNAc transferase (OGT) without inhibiting its catalytic function. Here, we repurpose a potent OGT inhibitor into a noninhibitory covalent probe using ligand-directed release chemistry (LDR). The resulting ligands covalently label OGT while preserving its enzymatic activity. Building on this scaffold, we developed a self-assembling O-GlcNAcylation Targeting Chimera (OGTAC) that recruits OGT to its native substrate casein kinase IIα (CK2α) in living cells, selectively elevating CK2α O-GlcNAcylation without affecting global modification levels. This new class of self-assembling chimeras covalently engages OGT to induce protein-specific
O-GlcNAcylation, offering a versatile platform for dissecting and controlling this essential modification in living cells. Our findings open the door to next-generation OGTACs and related therapeutic strategies for the targeted modulation of the O-GlcNAc signaling.
Type
Publication
ACS Chem. Biol. 2025, 20, 12, 2907–2916

Authors
Research Associate (Medicinal Chemistry)
Medicinal chemist designing novel antiviral and anticancer compounds. Researched nucleoside analogues at CUHK under Prof. Billy Ng since 2021, awarded Hong Kong Postdoctoral Fellowship 2022/2023. Enjoys exploring Hong Kong’s countryside and culture through photography.